Patents by Inventor Zhongmin Zhou

Zhongmin Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975315
    Abstract: Disclosed is a method for partially regenerating a catalyst for methanol and/or dimethyl ether-to-olefin. The method comprises: introducing a mixed gas into a regenerated region containing a catalyst to be regenerated, and subjecting same to a partial regeneration reaction to obtain a regenerated catalyst, wherein the mixed gas contains water vapor and air; and in the regenerated catalyst, the coke content of at least part of the regenerated catalyst is greater than 1%. The method utilizes the coupling of a mixed gas of water vapor and air to activate a deactivated catalyst, selectively eliminate part of a coke deposit in the catalyst to be regenerated, and obtain a partially regenerated catalyst for methanol-to-olefin. Another aspect of the present invention is that further provided is a method for methanol and/or dimethyl ether-to-olefin by using the partially regenerated catalyst for methanol-to-olefin regenerated by means of the method.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: May 7, 2024
    Assignee: DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES
    Inventors: Jinling Zhang, Mao Ye, Zhongmin Liu, Jibin Zhou, Tao Zhang, Xiangao Wang, Hailong Tang, Jing Wang
  • Patent number: 10961231
    Abstract: The invention provides cyclosporin A analogues that are NTCP inhibitors and useful for treating HBV and/or HDV infection(s), hepatoprotection and amelioration of hypercholesterolemia, diabetes and inhibiting cancer.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: March 30, 2021
    Assignee: National Institute of Biological Sciences, Beijing
    Inventors: Zhiyuan Zhang, Wenhui Li, Hanying Ruan, Yang Liu, Fengfeng Mao, Ying Li, Zhongmin Zhou
  • Publication number: 20210040072
    Abstract: The invention provides cyclosporin A analogues that are NTCP inhibitors and useful for treating HBV and/or HDV infection(s), hepatoprotection and amelioration of hypercholesterolemia, diabetes and inhibiting cancer.
    Type: Application
    Filed: October 12, 2020
    Publication date: February 11, 2021
    Applicant: National Institute of Biological Sciences, Beijing
    Inventors: Zhiyuan Zhang, Wenhui Li, Hanying Ruan, Yang Liu, Fengfeng Mao, Ying Li, Zhongmin Zhou